Cross-Sector entity

Epigenetic Clocks

Technology
5.5

COSMOS Trial is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. clinical-trial accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. Each carries 29.5 original sources on average. We currently track 2 Cross-Sector stories that mention Epigenetic Clocks, all published on March 9, 2026.

2 verified stories tracked

Last mentioned: Mar 9, 2026

Entity pulse

Recent coverage · Epigenetic Clocks

2 stories
5.5 avg impact
50% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 50 percentage points.

  • 50% positive
  • 50% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Epigenetic Clocks

COSMOS Trial is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. clinical-trial accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. Each carries 29.5 original sources on average. We currently track 2 Cross-Sector stories that mention Epigenetic Clocks, all published on March 9, 2026.

Stories tracked
2
Sources per story
29.5

Computed from the 2 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Epigenetic Clocks. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Biological Aging Analysis

    New data reveals daily multivitamins significantly slow epigenetic aging clocks.

  2. Cognitive & Clinical Results

    Initial findings on memory and cardiovascular outcomes published with mixed results.

  3. COSMOS Trial Launch

    Large-scale randomized trial begins investigating cocoa extract and multivitamins.

Stories mentioning Epigenetic Clocks 2

Biotech clinical trial Positive 6

COSMOS Trial: Daily Multivitamins Significantly Slow Biological Aging Clocks

A prespecified analysis of the large-scale COSMOS trial has found that daily multivitamin-multimineral supplementation significantly slows markers of biological aging in older adults. The study provides robust clinical evidence that standard nutritional interventions can influence cellular longevity and epigenetic health beyond simple deficiency prevention.

2 sources